UniSa - IRIS Institutional Research Information System

MAROTTA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.914
NA - Nord America 1.020
SA - Sud America 960
EU - Europa 268
AF - Africa 60
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.226
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.510
US - Stati Uniti d'America 947
BR - Brasile 720
SG - Singapore 493
VN - Vietnam 457
CN - Cina 220
AR - Argentina 91
FR - Francia 61
ID - Indonesia 53
IT - Italia 50
BD - Bangladesh 41
EC - Ecuador 37
MX - Messico 34
PY - Paraguay 33
CO - Colombia 32
IN - India 31
DE - Germania 22
GB - Regno Unito 19
UA - Ucraina 18
CA - Canada 17
CL - Cile 17
RU - Federazione Russa 17
TR - Turchia 17
IQ - Iraq 16
KR - Corea 16
ZA - Sudafrica 13
PL - Polonia 12
VE - Venezuela 12
MA - Marocco 11
EG - Egitto 10
JP - Giappone 10
UY - Uruguay 10
ES - Italia 8
KE - Kenya 8
NL - Olanda 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
LT - Lituania 6
PE - Perù 6
AL - Albania 5
PH - Filippine 5
PK - Pakistan 5
UZ - Uzbekistan 5
AT - Austria 4
AZ - Azerbaigian 4
MY - Malesia 4
RS - Serbia 4
SA - Arabia Saudita 4
SE - Svezia 4
CR - Costa Rica 3
DZ - Algeria 3
FI - Finlandia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
HR - Croazia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 8.222
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.508
San Jose 303
Ho Chi Minh City 174
Singapore 166
Dallas 144
Hanoi 103
Ashburn 87
Council Bluffs 72
Beijing 68
São Paulo 62
Lauterbourg 52
Rio de Janeiro 29
Da Nang 25
Haiphong 25
Santa Clara 25
New York 20
Curitiba 17
Los Angeles 17
Mexico City 17
Asunción 16
Boardman 16
Seoul 14
Thái Bình 14
Naples 13
Porto Alegre 13
Quito 12
Brasília 11
Buffalo 11
Ribeirão Preto 11
Woodbridge 11
Biên Hòa 10
Guayaquil 10
Ninh Bình 10
Salvador 10
Santo André 10
Houston 9
Phủ Lý 9
Santiago 9
Tokyo 9
Ann Arbor 8
Buenos Aires 8
Guarulhos 8
Montevideo 8
Orem 8
Cairo 7
Campinas 7
Frankfurt am Main 7
Hortolândia 7
Jacksonville 7
Jakarta 7
Manaus 7
Medellín 7
Munich 7
Baghdad 6
Belo Horizonte 6
Bắc Giang 6
Caxias do Sul 6
Chandler 6
Cuiabá 6
Hải Dương 6
Johannesburg 6
Maceió 6
Memphis 6
Nairobi 6
Piracicaba 6
Recife 6
Volta Redonda 6
Warsaw 6
Bắc Ninh 5
Canoas 5
Coimbatore 5
Dublin 5
Izmir 5
Kyiv 5
Montreal 5
Nha Trang 5
Nuremberg 5
Poplar 5
Rome 5
San Juan 5
Santiago de Cali 5
Sumaré 5
Taiyuan 5
Tashkent 5
Araçatuba 4
Baku 4
Bauru 4
Caracas 4
Charlotte 4
Chicago 4
Duque de Caxias 4
Feira de Santana 4
Fisciano 4
Florianópolis 4
Formosa 4
Gdansk 4
Ha Long 4
Huế 4
Joinville 4
Juiz de Fora 4
Totale 6.479
Salva come PNG Salva come JPEG
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 724
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 485
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 397
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 328
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 325
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 320
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 319
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 277
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 271
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 244
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 206
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 200
GH provocative tests stimulate the growth in children with idiopathic short stature 188
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 157
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 144
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 134
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 124
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 120
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 116
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 108
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 106
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 102
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 102
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 99
Benign thyroid nodules with RAS mutation grow faster 97
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 92
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 90
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 86
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 85
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 85
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 84
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 82
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 81
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 78
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 78
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 77
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 76
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 72
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 71
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 69
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 69
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 67
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 66
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 65
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 65
Radioiodide induces apoptosis in human thyroid tissue in culture 64
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 64
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 63
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 63
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 60
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 60
Growing thyroid nodules with benign histology and RET rearrangement 59
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 58
The evolving field of kinase inhibitors in thyroid cancer 57
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 56
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 52
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 52
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 52
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 51
Limitations of Chromogranin A in clinical practice 50
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 48
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 45
Hepatic arterial embolization in patients with neuroendocrine tumors 41
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context 27
La diagnostica molecolare del nodulo tiroideo 27
Beyond the Genome: Can Epigenetics Forecast Therapeutic Success in Graves’ Disease and Thyroid Eye Disease? 12
Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma 5
Modulation of chemokine secretion and oxidative stress in vitro in thyroid cells after exposure to thiocyanate, nitrate, or perchlorate 1
Pathophysiology and treatment of exercise-associated hyponatremia 1
Totale 8.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20268.226 586 2.769 2.215 1.004 335 101 259 203 193 402 124 35
Totale 8.299